Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Afatinib × Clear all

Phase

Status

Completed 78 Unknown 15 Terminated 15 Recruiting 11 Withdrawn 6 Active not recruiting 5 Suspended 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 28 Magnetic Resonance Spectroscopy 20 Biopsy 16 Cyclophosphamide 14 Paclitaxel 8 Nivolumab 8 Bevacizumab 8 Gemcitabine 7 Cisplatin 7 pembrolizumab 6 Docetaxel 6 Vincristine 5 Radiotherapy 5 Radiosurgery 5 Prednisone 5 Fluorouracil 5 Doxorubicin 5 Carboplatin 5 Capecitabine 5 fludarabine 4 atezolizumab 4 Rituximab 4 Radiation 4 Oxaliplatin 4 Lenalidomide 4 Ipilimumab 4 Etoposide 4 Drug Therapy 4 Azacitidine 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02470065 2016-01-22

REMNANT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡